| Symbol |
Name |
|
ABCA3
|
ATP-binding cassette, sub-family A (ABC1), member 3
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACSF3
|
acyl-CoA synthetase family member 3
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM19
|
ADAM metallopeptidase domain 19
|
|
ADARB1
|
adenosine deaminase, RNA-specific, B1
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AFF3
|
AF4/FMR2 family, member 3
|
|
AHI1
|
Abelson helper integration site 1
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AICDA
|
activation-induced cytidine deaminase
|
|
AIFM1
|
apoptosis-inducing factor, mitochondrion-associated, 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
AKT2
|
v-akt murine thymoma viral oncogene homolog 2
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALOX15
|
arachidonate 15-lipoxygenase
|
|
ALOX5
|
arachidonate 5-lipoxygenase
|
|
ANG
|
angiogenin, ribonuclease, RNase A family, 5
|
|
ANGPT2
|
angiopoietin 2
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
APAF1
|
apoptotic peptidase activating factor 1
|
|
APOBEC3B
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B
|
|
APOBEC3G
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
AR
|
androgen receptor
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASNS
|
asparagine synthetase (glutamine-hydrolyzing)
|
|
ATM
|
ATM serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
B2M
|
beta-2-microglobulin
|
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2
|
|
BAD
|
BCL2-associated agonist of cell death
|
|
BAG3
|
BCL2-associated athanogene 3
|
|
BAG5
|
BCL2-associated athanogene 5
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BCL10
|
B-cell CLL/lymphoma 10
|
|
BCL11A
|
B-cell CLL/lymphoma 11A (zinc finger protein)
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2A1
|
BCL2-related protein A1
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL3
|
B-cell CLL/lymphoma 3
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCL7A
|
B-cell CLL/lymphoma 7A
|
|
BCLAF1
|
BCL2-associated transcription factor 1
|
|
BECN1
|
beclin 1, autophagy related
|
|
BIRC3
|
baculoviral IAP repeat containing 3
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BLM
|
Bloom syndrome, RecQ helicase-like
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BMP7
|
bone morphogenetic protein 7
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRD2
|
bromodomain containing 2
|
|
BRD4
|
bromodomain containing 4
|
|
BSG
|
basigin (Ok blood group)
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
BTLA
|
B and T lymphocyte associated
|
|
BTRC
|
beta-transducin repeat containing E3 ubiquitin protein ligase
|
|
BUB1
|
BUB1 mitotic checkpoint serine/threonine kinase
|
|
BUB1B
|
BUB1 mitotic checkpoint serine/threonine kinase B
|
|
C1QA
|
complement component 1, q subcomponent, A chain
|
|
CADM1
|
cell adhesion molecule 1
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CARS
|
cysteinyl-tRNA synthetase
|
|
CASP1
|
caspase 1, apoptosis-related cysteine peptidase
|
|
CASP10
|
caspase 10, apoptosis-related cysteine peptidase
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CBFA2T3
|
core-binding factor, runt domain, alpha subunit 2; translocated to, 3
|
|
CBL
|
Cbl proto-oncogene, E3 ubiquitin protein ligase
|
|
CCDC50
|
coiled-coil domain containing 50
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL19
|
chemokine (C-C motif) ligand 19
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL20
|
chemokine (C-C motif) ligand 20
|
|
CCL21
|
chemokine (C-C motif) ligand 21
|
|
CCL26
|
chemokine (C-C motif) ligand 26
|
|
CCNA2
|
cyclin A2
|
|
CCNB1
|
cyclin B1
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCND3
|
cyclin D3
|
|
CCNE1
|
cyclin E1
|
|
CCNH
|
cyclin H
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCR10
|
chemokine (C-C motif) receptor 10
|
|
CCR3
|
chemokine (C-C motif) receptor 3
|
|
CCR4
|
chemokine (C-C motif) receptor 4
|
|
CCR6
|
chemokine (C-C motif) receptor 6
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD14
|
CD14 molecule
|
|
CD160
|
CD160 molecule
|
|
CD163
|
CD163 molecule
|
|
CD19
|
CD19 molecule
|
|
CD1D
|
CD1d molecule
|
|
CD200
|
CD200 molecule
|
|
CD22
|
CD22 molecule
|
|
CD27
|
CD27 molecule
|
|
CD274
|
CD274 molecule
|
|
CD28
|
CD28 molecule
|
|
CD302
|
CD302 molecule
|
|
CD33
|
CD33 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD4
|
CD4 molecule
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD5
|
CD5 molecule
|
|
CD55
|
CD55 molecule, decay accelerating factor for complement (Cromer blood group)
|
|
CD58
|
CD58 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CD68
|
CD68 molecule
|
|
CD7
|
CD7 molecule
|
|
CD70
|
CD70 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD79A
|
CD79a molecule, immunoglobulin-associated alpha
|
|
CD79B
|
CD79b molecule, immunoglobulin-associated beta
|
|
CD80
|
CD80 molecule
|
|
CD81
|
CD81 molecule
|
|
CD83
|
CD83 molecule
|
|
CD86
|
CD86 molecule
|
|
CD8A
|
CD8a molecule
|
|
CD9
|
CD9 molecule
|
|
CD99
|
CD99 molecule
|
|
CDA
|
cytidine deaminase
|
|
CDC25A
|
cell division cycle 25A
|
|
CDC25B
|
cell division cycle 25B
|
|
CDC42
|
cell division cycle 42
|
|
CDC7
|
cell division cycle 7
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDKN2B
|
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)
|
|
CDKN2C
|
cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)
|
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CEP85L
|
centrosomal protein 85kDa-like
|
|
CES2
|
carboxylesterase 2
|
|
CFAP69
|
cilia and flagella associated protein 69
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CKS1B
|
CDC28 protein kinase regulatory subunit 1B
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLU
|
clusterin
|
|
CMIP
|
c-Maf inducing protein
|
|
CNN3
|
calponin 3, acidic
|
|
CNR1
|
cannabinoid receptor 1 (brain)
|
|
COPS5
|
COP9 signalosome subunit 5
|
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2
|
|
CREBBP
|
CREB binding protein
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF1R
|
colony stimulating factor 1 receptor
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK1A1
|
casein kinase 1, alpha 1
|
|
CT45A1
|
cancer/testis antigen family 45, member A1
|
|
CTAGE1
|
cutaneous T-cell lymphoma-associated antigen 1
|
|
CTGF
|
connective tissue growth factor
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSD
|
cathepsin D
|
|
CX3CR1
|
chemokine (C-X3-C motif) receptor 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL13
|
chemokine (C-X-C motif) ligand 13
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR3
|
chemokine (C-X-C motif) receptor 3
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CXCR5
|
chemokine (C-X-C motif) receptor 5
|
|
CYB5B
|
cytochrome b5 type B (outer mitochondrial membrane)
|
|
CYBA
|
cytochrome b-245, alpha polypeptide
|
|
CYBB
|
cytochrome b-245, beta polypeptide
|
|
CYLD
|
cylindromatosis (turban tumor syndrome)
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
DAPK1
|
death-associated protein kinase 1
|
|
DCK
|
deoxycytidine kinase
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DICER1
|
dicer 1, ribonuclease type III
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLEC1
|
deleted in lung and esophageal cancer 1
|
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DNMT3A
|
DNA (cytosine-5-)-methyltransferase 3 alpha
|
|
DOK1
|
docking protein 1, 62kDa (downstream of tyrosine kinase 1)
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DUSP2
|
dual specificity phosphatase 2
|
|
E2F1
|
E2F transcription factor 1
|
|
E2F4
|
E2F transcription factor 4, p107/p130-binding
|
|
EBF1
|
early B-cell factor 1
|
|
EBI3
|
Epstein-Barr virus induced 3
|
|
EED
|
embryonic ectoderm development
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2S1
|
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa
|
|
EIF4E
|
eukaryotic translation initiation factor 4E
|
|
EML4
|
echinoderm microtubule associated protein like 4
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
ENPP2
|
ectonucleotide pyrophosphatase/phosphodiesterase 2
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB4
|
erb-b2 receptor tyrosine kinase 4
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
ETV6
|
ets variant 6
|
|
ETV7
|
ets variant 7
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
FABP7
|
fatty acid binding protein 7, brain
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBXO25
|
F-box protein 25
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR2B
|
Fc fragment of IgG, low affinity IIb, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCRL4
|
Fc receptor-like 4
|
|
FCRL5
|
Fc receptor-like 5
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGFR2
|
fibroblast growth factor receptor 2
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FIGF
|
c-fos induced growth factor (vascular endothelial growth factor D)
|
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FMOD
|
fibromodulin
|
|
FN1
|
fibronectin 1
|
|
FOS
|
FBJ murine osteosarcoma viral oncogene homolog
|
|
FOSL2
|
FOS-like antigen 2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP1
|
forkhead box P1
|
|
FOXP3
|
forkhead box P3
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FYN
|
FYN proto-oncogene, Src family tyrosine kinase
|
|
G6PD
|
glucose-6-phosphate dehydrogenase
|
|
GAS5
|
growth arrest-specific 5 (non-protein coding)
|
|
GATA3
|
GATA binding protein 3
|
|
GCSAM
|
germinal center-associated, signaling and motility
|
|
GFI1B
|
growth factor independent 1B transcription repressor
|
|
GH1
|
growth hormone 1
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLI2
|
GLI family zinc finger 2
|
|
GLI3
|
GLI family zinc finger 3
|
|
GLS
|
glutaminase
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNLY
|
granulysin
|
|
GPC5
|
glypican 5
|
|
GPR34
|
G protein-coupled receptor 34
|
|
GRB2
|
growth factor receptor-bound protein 2
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM3
|
glutathione S-transferase mu 3 (brain)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)
|
|
H2AFX
|
H2A histone family, member X
|
|
H3F3A
|
H3 histone, family 3A
|
|
HACE1
|
HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAVCR2
|
hepatitis A virus cellular receptor 2
|
|
HAX1
|
HCLS1 associated protein X-1
|
|
HCK
|
HCK proto-oncogene, Src family tyrosine kinase
|
|
HDAC1
|
histone deacetylase 1
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC3
|
histone deacetylase 3
|
|
HDAC6
|
histone deacetylase 6
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HGFAC
|
HGF activator
|
|
HIC1
|
hypermethylated in cancer 1
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HIST1H1B
|
histone cluster 1, H1b
|
|
HIST1H1C
|
histone cluster 1, H1c
|
|
HIST1H1D
|
histone cluster 1, H1d
|
|
HIST1H1E
|
histone cluster 1, H1e
|
|
HIST3H3
|
histone cluster 3, H3
|
|
HIST4H4
|
histone cluster 4, H4
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGA1
|
high mobility group AT-hook 1
|
|
HMGB1
|
high mobility group box 1
|
|
HOXB9
|
homeobox B9
|
|
HPSE
|
heparanase
|
|
HSD17B1
|
hydroxysteroid (17-beta) dehydrogenase 1
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90B1
|
heat shock protein 90kDa beta (Grp94), member 1
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPH1
|
heat shock 105kDa/110kDa protein 1
|
|
HTRA2
|
HtrA serine peptidase 2
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
ICAM3
|
intercellular adhesion molecule 3
|
|
ICOS
|
inducible T-cell co-stimulator
|
|
ID2
|
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNAR2
|
interferon (alpha, beta and omega) receptor 2
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2BP1
|
insulin-like growth factor 2 mRNA binding protein 1
|
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGK
|
immunoglobulin kappa locus
|
|
IGL
|
immunoglobulin lambda locus
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IKZF1
|
IKAROS family zinc finger 1 (Ikaros)
|
|
IKZF2
|
IKAROS family zinc finger 2 (Helios)
|
|
IKZF3
|
IKAROS family zinc finger 3 (Aiolos)
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL11RA
|
interleukin 11 receptor, alpha
|
|
IL12A
|
interleukin 12A
|
|
IL12B
|
interleukin 12B
|
|
IL12RB2
|
interleukin 12 receptor, beta 2
|
|
IL15
|
interleukin 15
|
|
IL15RA
|
interleukin 15 receptor, alpha
|
|
IL16
|
interleukin 16
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R2
|
interleukin 1 receptor, type II
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL21
|
interleukin 21
|
|
IL21R
|
interleukin 21 receptor
|
|
IL22
|
interleukin 22
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL2RB
|
interleukin 2 receptor, beta
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL32
|
interleukin 32
|
|
IL3RA
|
interleukin 3 receptor, alpha (low affinity)
|
|
IL4
|
interleukin 4
|
|
IL4I1
|
interleukin 4 induced 1
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
IL9
|
interleukin 9
|
|
IL9R
|
interleukin 9 receptor
|
|
ILK
|
integrin-linked kinase
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF4
|
interferon regulatory factor 4
|
|
IRF5
|
interferon regulatory factor 5
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRF8
|
interferon regulatory factor 8
|
|
ISL1
|
ISL LIM homeobox 1
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITK
|
IL2-inducible T-cell kinase
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JAK3
|
Janus kinase 3
|
|
JUN
|
jun proto-oncogene
|
|
JUNB
|
jun B proto-oncogene
|
|
JUND
|
jun D proto-oncogene
|
|
KAT2B
|
K(lysine) acetyltransferase 2B
|
|
KCNA3
|
potassium channel, voltage gated shaker related subfamily A, member 3
|
|
KDM4C
|
lysine (K)-specific demethylase 4C
|
|
KDR
|
kinase insert domain receptor
|
|
KDSR
|
3-ketodihydrosphingosine reductase
|
|
KIF2A
|
kinesin heavy chain member 2A
|
|
KIF5B
|
kinesin family member 5B
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KLF2
|
Kruppel-like factor 2
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLRC1
|
killer cell lectin-like receptor subfamily C, member 1
|
|
KLRD1
|
killer cell lectin-like receptor subfamily D, member 1
|
|
KLRK1
|
killer cell lectin-like receptor subfamily K, member 1
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KMT2D
|
lysine (K)-specific methyltransferase 2D
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT81
|
keratin 81, type II
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMP1
|
lysosomal-associated membrane protein 1
|
|
LCK
|
LCK proto-oncogene, Src family tyrosine kinase
|
|
LDHA
|
lactate dehydrogenase A
|
|
LEF1
|
lymphoid enhancer-binding factor 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3
|
|
LMO2
|
LIM domain only 2 (rhombotin-like 1)
|
|
LPP
|
LIM domain containing preferred translocation partner in lipoma
|
|
LRP2
|
low density lipoprotein receptor-related protein 2
|
|
LTA
|
lymphotoxin alpha
|
|
LY75
|
lymphocyte antigen 75
|
|
LYN
|
LYN proto-oncogene, Src family tyrosine kinase
|
|
MAF
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog
|
|
MAGEA3
|
melanoma antigen family A3
|
|
MALT1
|
MALT1 paracaspase
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAP3K7
|
mitogen-activated protein kinase kinase kinase 7
|
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8
|
|
MAP4
|
microtubule-associated protein 4
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MECP2
|
methyl CpG binding protein 2
|
|
MEF2B
|
myocyte enhancer factor 2B
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MFHAS1
|
malignant fibrous histiocytoma amplified sequence 1
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MICB
|
MHC class I polypeptide-related sequence B
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MINA
|
MYC induced nuclear antigen
|
|
MIR106B
|
microRNA 106b
|
|
MIR135A1
|
microRNA 135a-1
|
|
MIR135B
|
microRNA 135b
|
|
MIR142
|
microRNA 142
|
|
MIR143
|
microRNA 143
|
|
MIR145
|
microRNA 145
|
|
MIR146A
|
microRNA 146a
|
|
MIR146B
|
microRNA 146b
|
|
MIR148B
|
microRNA 148b
|
|
MIR150
|
microRNA 150
|
|
MIR155
|
microRNA 155
|
|
MIR155HG
|
MIR155 host gene
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR16-2
|
microRNA 16-2
|
|
MIR17
|
microRNA 17
|
|
MIR181A2
|
microRNA 181a-2
|
|
MIR200A
|
microRNA 200a
|
|
MIR200B
|
microRNA 200b
|
|
MIR200C
|
microRNA 200c
|
|
MIR203A
|
microRNA 203a
|
|
MIR20A
|
microRNA 20a
|
|
MIR21
|
microRNA 21
|
|
MIR210
|
microRNA 210
|
|
MIR223
|
microRNA 223
|
|
MIR23A
|
microRNA 23a
|
|
MIR24-1
|
microRNA 24-1
|
|
MIR26A1
|
microRNA 26a-1
|
|
MIR26B
|
microRNA 26b
|
|
MIR28
|
microRNA 28
|
|
MIR29A
|
microRNA 29a
|
|
MIR29B1
|
microRNA 29b-1
|
|
MIR320D1
|
microRNA 320d-1
|
|
MIR34A
|
microRNA 34a
|
|
MIR502
|
microRNA 502
|
|
MIR548M
|
microRNA 548m
|
|
MIR618
|
microRNA 618
|
|
MIR9-1
|
microRNA 9-1
|
|
MIR92A1
|
microRNA 92a-1
|
|
MIR96
|
microRNA 96
|
|
MIXL1
|
Mix paired-like homeobox
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MKNK1
|
MAP kinase interacting serine/threonine kinase 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MNDA
|
myeloid cell nuclear differentiation antigen
|
|
MNX1
|
motor neuron and pancreas homeobox 1
|
|
MOS
|
v-mos Moloney murine sarcoma viral oncogene homolog
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MRPL37
|
mitochondrial ribosomal protein L37
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSC
|
musculin
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT1A
|
metallothionein 1A
|
|
MT2A
|
metallothionein 2A
|
|
MTAP
|
methylthioadenosine phosphorylase
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUM1
|
melanoma associated antigen (mutated) 1
|
|
MVP
|
major vault protein
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYD88
|
myeloid differentiation primary response 88
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
MZB1
|
marginal zone B and B1 cell-specific protein
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NAPRT
|
nicotinate phosphoribosyltransferase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NAV3
|
neuron navigator 3
|
|
NBN
|
nibrin
|
|
NCAM1
|
neural cell adhesion molecule 1
|
|
NCR1
|
natural cytotoxicity triggering receptor 1
|
|
NDP
|
Norrie disease (pseudoglioma)
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NFATC2
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NFKB2
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100)
|
|
NFKBIA
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha
|
|
NFKBIZ
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta
|
|
NKAIN2
|
Na+/K+ transporting ATPase interacting 2
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOTCH1
|
notch 1
|
|
NOTCH2
|
notch 2
|
|
NPAS2
|
neuronal PAS domain protein 2
|
|
NPAT
|
nuclear protein, ataxia-telangiectasia locus
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NTSR1
|
neurotensin receptor 1 (high affinity)
|
|
NUCLEOLIN
|
nucleolin multifunctional protein
|
|
ONECUT2
|
one cut homeobox 2
|
|
ORC4
|
origin recognition complex, subunit 4
|
|
OTX1
|
orthodenticle homeobox 1
|
|
P2RY8
|
purinergic receptor P2Y, G-protein coupled, 8
|
|
PABPC1
|
poly(A) binding protein, cytoplasmic 1
|
|
PAG1
|
phosphoprotein membrane anchor with glycosphingolipid microdomains 1
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX5
|
paired box 5
|
|
PBK
|
PDZ binding kinase
|
|
PCDH10
|
protocadherin 10
|
|
PCM1
|
pericentriolar material 1
|
|
PCSK1
|
proprotein convertase subtilisin/kexin type 1
|
|
PCSK2
|
proprotein convertase subtilisin/kexin type 2
|
|
PDCD1
|
programmed cell death 1
|
|
PDCD1LG2
|
programmed cell death 1 ligand 2
|
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific
|
|
PDE7B
|
phosphodiesterase 7B
|
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PEBP4
|
phosphatidylethanolamine-binding protein 4
|
|
PEG10
|
paternally expressed 10
|
|
PER2
|
period circadian clock 2
|
|
PGP
|
phosphoglycolate phosphatase
|
|
PGR
|
progesterone receptor
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM1
|
Pim-1 proto-oncogene, serine/threonine kinase
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G2A
|
phospholipase A2, group IIA (platelets, synovial fluid)
|
|
PLAGL1
|
pleiomorphic adenoma gene-like 1
|
|
PLCG1
|
phospholipase C, gamma 1
|
|
PLD2
|
phospholipase D2
|
|
PLIN2
|
perilipin 2
|
|
PLK1
|
polo-like kinase 1
|
|
PLS3
|
plastin 3
|
|
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1
|
|
PML
|
promyelocytic leukemia
|
|
POLI
|
polymerase (DNA directed) iota
|
|
POLM
|
polymerase (DNA directed), mu
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F2
|
POU class 2 homeobox 2
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPID
|
peptidylprolyl isomerase D
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRDM1
|
PR domain containing 1, with ZNF domain
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAG3
|
protein kinase, AMP-activated, gamma 3 non-catalytic subunit
|
|
PRKCB
|
protein kinase C, beta
|
|
PRKCD
|
protein kinase C, delta
|
|
PRKCH
|
protein kinase C, eta
|
|
PRKCQ
|
protein kinase C, theta
|
|
PRL
|
prolactin
|
|
PRMT5
|
protein arginine methyltransferase 5
|
|
PRPF6
|
pre-mRNA processing factor 6
|
|
PRRC2A
|
proline-rich coiled-coil 2A
|
|
PSMB1
|
proteasome (prosome, macropain) subunit, beta type, 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTN
|
pleiotrophin
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN6
|
protein tyrosine phosphatase, non-receptor type 6
|
|
PTPRC
|
protein tyrosine phosphatase, receptor type, C
|
|
PTPRG
|
protein tyrosine phosphatase, receptor type, G
|
|
PTPRJ
|
protein tyrosine phosphatase, receptor type, J
|
|
PTPRO
|
protein tyrosine phosphatase, receptor type, O
|
|
PTPRZ1
|
protein tyrosine phosphatase, receptor-type, Z polypeptide 1
|
|
PVRL2
|
poliovirus receptor-related 2 (herpesvirus entry mediator B)
|
|
RAC1
|
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1)
|
|
RAD50
|
RAD50 homolog (S. cerevisiae)
|
|
RANBP2
|
RAN binding protein 2
|
|
RASGRF2
|
Ras protein-specific guanine nucleotide-releasing factor 2
|
|
RASSF1
|
Ras association (RalGDS/AF-6) domain family member 1
|
|
RB1
|
retinoblastoma 1
|
|
RBL2
|
retinoblastoma-like 2
|
|
RDH11
|
retinol dehydrogenase 11 (all-trans/9-cis/11-cis)
|
|
RECQL4
|
RecQ protein-like 4
|
|
REL
|
v-rel avian reticuloendotheliosis viral oncogene homolog
|
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A
|
|
RELB
|
v-rel avian reticuloendotheliosis viral oncogene homolog B
|
|
RFC1
|
replication factor C (activator 1) 1, 145kDa
|
|
RGS1
|
regulator of G-protein signaling 1
|
|
RGS13
|
regulator of G-protein signaling 13
|
|
RGS2
|
regulator of G-protein signaling 2
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHOA
|
ras homolog family member A
|
|
RHOH
|
ras homolog family member H
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RIPK4
|
receptor-interacting serine-threonine kinase 4
|
|
RNASET2
|
ribonuclease T2
|
|
RNF213
|
ring finger protein 213
|
|
RNF31
|
ring finger protein 31
|
|
ROR1
|
receptor tyrosine kinase-like orphan receptor 1
|
|
RPS6
|
ribosomal protein S6
|
|
RPS6KB1
|
ribosomal protein S6 kinase, 70kDa, polypeptide 1
|
|
RRAD
|
Ras-related associated with diabetes
|
|
RRM2
|
ribonucleotide reductase M2
|
|
RYR1
|
ryanodine receptor 1 (skeletal)
|
|
S1PR1
|
sphingosine-1-phosphate receptor 1
|
|
S1PR2
|
sphingosine-1-phosphate receptor 2
|
|
SDC1
|
syndecan 1
|
|
SEC31A
|
SEC31 homolog A (S. cerevisiae)
|
|
SEL1L
|
sel-1 suppressor of lin-12-like (C. elegans)
|
|
SELE
|
selectin E
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA9
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9
|
|
SERPINB9
|
serpin peptidase inhibitor, clade B (ovalbumin), member 9
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SETD8
|
SET domain containing (lysine methyltransferase) 8
|
|
SFPQ
|
splicing factor proline/glutamine-rich
|
|
SGMS1
|
sphingomyelin synthase 1
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SHH
|
sonic hedgehog
|
|
SHMT1
|
serine hydroxymethyltransferase 1 (soluble)
|
|
SIK2
|
salt-inducible kinase 2
|
|
SIN3A
|
SIN3 transcription regulator family member A
|
|
SIRT1
|
sirtuin 1
|
|
SIRT4
|
sirtuin 4
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLAMF1
|
signaling lymphocytic activation molecule family member 1
|
|
SLC16A1
|
solute carrier family 16 (monocarboxylate transporter), member 1
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC22A8
|
solute carrier family 22 (organic anion transporter), member 8
|
|
SLC23A1
|
solute carrier family 23 (ascorbic acid transporter), member 1
|
|
SLC23A2
|
solute carrier family 23 (ascorbic acid transporter), member 2
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC2A3
|
solute carrier family 2 (facilitated glucose transporter), member 3
|
|
SMC2
|
structural maintenance of chromosomes 2
|
|
SMC4
|
structural maintenance of chromosomes 4
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAI2
|
snail family zinc finger 2
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SOCS3
|
suppressor of cytokine signaling 3
|
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing
|
|
SOX11
|
SRY (sex determining region Y)-box 11
|
|
SOX5
|
SRY (sex determining region Y)-box 5
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK2
|
sphingosine kinase 2
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPN
|
sialophorin
|
|
SPRR1A
|
small proline-rich protein 1A
|
|
SPRY2
|
sprouty homolog 2 (Drosophila)
|
|
SPTA1
|
spectrin, alpha, erythrocytic 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
SUZ12
|
SUZ12 polycomb repressive complex 2 subunit
|
|
SYK
|
spleen tyrosine kinase
|
|
TACSTD2
|
tumor-associated calcium signal transducer 2
|
|
TAP2
|
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)
|
|
TBL1XR1
|
transducin (beta)-like 1 X-linked receptor 1
|
|
TBX21
|
T-box 21
|
|
TCF3
|
transcription factor 3
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TCN2
|
transcobalamin II
|
|
TENM2
|
teneurin transmembrane protein 2
|
|
TERF2
|
telomeric repeat binding factor 2
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET1
|
tet methylcytosine dioxygenase 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFDP1
|
transcription factor Dp-1
|
|
TFG
|
TRK-fused gene
|
|
TG
|
thyroglobulin
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR2
|
transforming growth factor, beta receptor II (70/80kDa)
|
|
THBS1
|
thrombospondin 1
|
|
THBS4
|
thrombospondin 4
|
|
TIA1
|
TIA1 cytotoxic granule-associated RNA binding protein
|
|
TIAM1
|
T-cell lymphoma invasion and metastasis 1
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TJP1
|
tight junction protein 1
|
|
TK1
|
thymidine kinase 1, soluble
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR9
|
toll-like receptor 9
|
|
TLX1
|
T-cell leukemia homeobox 1
|
|
TMEM176A
|
transmembrane protein 176A
|
|
TMEM176B
|
transmembrane protein 176B
|
|
TMEM260
|
transmembrane protein 260
|
|
TNF
|
tumor necrosis factor
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF13B
|
tumor necrosis factor receptor superfamily, member 13B
|
|
TNFRSF13C
|
tumor necrosis factor receptor superfamily, member 13C
|
|
TNFRSF14
|
tumor necrosis factor receptor superfamily, member 14
|
|
TNFRSF1A
|
tumor necrosis factor receptor superfamily, member 1A
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFRSF6B
|
tumor necrosis factor receptor superfamily, member 6b, decoy
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFRSF9
|
tumor necrosis factor receptor superfamily, member 9
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF13
|
tumor necrosis factor (ligand) superfamily, member 13
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNIP1
|
TNFAIP3 interacting protein 1
|
|
TNIP2
|
TNFAIP3 interacting protein 2
|
|
TNK1
|
tyrosine kinase, non-receptor, 1
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TRA
|
T cell receptor alpha locus
|
|
TRAF1
|
TNF receptor-associated factor 1
|
|
TRAF3
|
TNF receptor-associated factor 3
|
|
TRB
|
T cell receptor beta locus
|
|
TRBV6-2
|
T cell receptor beta variable 6-2 (gene/pseudogene)
|
|
TRD
|
T cell receptor delta locus
|
|
TRG
|
T cell receptor gamma locus
|
|
TSN
|
translin
|
|
TTR
|
transthyretin
|
|
TUBB2A
|
tubulin, beta 2A class IIa
|
|
TUBB3
|
tubulin, beta 3 class III
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXN
|
thioredoxin
|
|
TYMS
|
thymidylate synthetase
|
|
UBA1
|
ubiquitin-like modifier activating enzyme 1
|
|
UBR5
|
ubiquitin protein ligase E3 component n-recognin 5
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UQCC1
|
ubiquinol-cytochrome c reductase complex assembly factor 1
|
|
USP18
|
ubiquitin specific peptidase 18
|
|
VAV1
|
vav 1 guanine nucleotide exchange factor
|
|
VCAN
|
versican
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WNT10A
|
wingless-type MMTV integration site family, member 10A
|
|
WNT3
|
wingless-type MMTV integration site family, member 3
|
|
WNT5A
|
wingless-type MMTV integration site family, member 5A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
XBP1
|
X-box binding protein 1
|
|
XCR1
|
chemokine (C motif) receptor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPA
|
xeroderma pigmentosum, complementation group A
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZAP70
|
zeta-chain (TCR) associated protein kinase 70kDa
|
|
ZBTB16
|
zinc finger and BTB domain containing 16
|
|
ZBTB7A
|
zinc finger and BTB domain containing 7A
|
|
ZC3HC1
|
zinc finger, C3HC-type containing 1
|
|
ZEB1
|
zinc finger E-box binding homeobox 1
|
|
ZHX2
|
zinc fingers and homeoboxes 2
|
